Our analysis also showed no correlation between CSPG4P12 and expression levels of commonly mutated genes in CRC patients (P53, KRAS, c-myc, Hras, Nras, Myb) (Supplementary Figure S1). This evidence concerns the gene KRAS and colorectal carcinoma.